abstract |
The present invention relates to a tetrahydrocannabinol derivative and the medical use thereof. Specifically, the present invention relates to a pyrimidine derivative as shown in general formula (I) or a stereoisomer, a solvate, a metabolite, a pharmaceutically acceptable salt or a co-crystal thereof, wherein the definition of each substituent in general formula (I) is the same as the definition in the description. |